192
Views
1
CrossRef citations to date
0
Altmetric
Research Article

How the Incomplete Medicalization of Cannabis Shapes Patient Experiences

References

  • Abrams, Donald I., Paul Couey, Starley B. Shade, M. E. Kelly, and Neal L. Benowitz. 2011. “Cannabinoid-Opioid Interaction in Chronic Pain.” Clinical Pharmacology and Therapeutics 90(6): 844–51. doi:10.1038/clpt.2011.188.
  • Alexandra, Sideris, Fahad Khan, Alina Boltunova, Germaine Cuff, Christopher Gharibo, and Lisa V. Doan. 2018. “New York Physicians’ Perspectives and Knowledge of the State Medical Marijuana Program.” Cannabis and Cannabinoid Research 3(1): 74–84. doi:10.1089/can.2017.0046.
  • Athey, Nicholas, Neil Boyd, and Elysha Cohen. 2017. “Becoming a Medical Marijuana User: Reflections on Becker’s Trilogy—Learning Techniques, Experiencing Effects, and Perceiving Those Effects as Enjoyable.” Contemporary Drug Problems 44(3): 212–31. doi:10.1177/0091450917721206.
  • Ballard, K. and M. A. Elston. 2005. “Medicalisation: A Multi-Dimensional Concept.” Social Theory & Health 3(3): 228–41. doi:10.1057/palgrave.sth.8700053.
  • Ballotpedia. 2019. “Michigan Medical Marijuana Initiative, Proposal.” 1 2008. https://ballotpedia.org/Michigan_Medical_Marijuana_Initiative,_Proposal_1_(2008)
  • Barker, K. K. 2014. “Mindfulness Meditation: Do-It-Yourself Medicalization of Every Moment.” Social Science & Medicine 106: 168–76. doi:10.1016/j.socscimed.2014.01.024.
  • Beau, Kilmer and Robert J. MacCoun. 2017. “How Medical Marijuana Smoothed the Transition to Marijuana Legalisation in the United States.” Annual Review of Law and Social Science 13: 181–202. doi:10.1146/annurev-lawsocsci-110615-084851.
  • Berg, Bruce L. 2009. Qualitative Research Methods for the Social Sciences. Boston, MA: Allyn & Bacon.
  • Biolchini, A. 2019 July 9. “Michigan’s Medical Marijuana Market Could Crash after Recreational Shops Launch.” MLive. https://www.mlive.com/news/2019/07/michigans-medical-marijuana-market-could-crash-after-recreational-shops-launch.html.
  • Bloor, Michael, Jane Frankland, Michelle Thomas, and Kate Robson. 2001. Focus Groups in Social Research. Thousand Oaks, CA: Sage.
  • Boddy, C. R. 2016. “Sample Size for Qualitative Research.” Qualitative Market Research: An International Journal 19(4): 426–32. doi:10.1108/QMR-06-2016-0053.
  • Boehnke, Kevin F., Evangelos Litinas, and Daniel J. Clauw. 2016. “Medical Cannabis Use Is Associated with Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients with Chronic Pain.” The Journal of Pain 17(6): 739–44. doi:10.1016/j.jpain.2016.03.002.
  • Bostwick, J. Michael 2012. “Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana.” Mayo Clinic Proceedings 87(2):172–86.
  • Bottorff, Joan L., Laura J.L. Bissell, Lynda G. Balneaves, John L. Oliffe, H. Bindy K. Kang, N. Rielle Capler, Jane. A. Buxton, and Robin K. O’Brien. 2011. “Health Effects of Using Cannabis for Therapeutic Purposes: A Gender Analysis of Users’ Perspectives.” Substance Use & Misuse 46(6): 769–80. doi:10.3109/10826084.2010.537732.
  • Bottorff, Joan L., Laura JL Bissell, Lynda G. Balneaves, John L Oliffe, N Rielle Capler, and Jane Buxton. 2013. “Perceptions of Cannabis as A Stigmatised Medicine: A Qualitative Descriptive Study.” Harm Reduction Journal 10(2): 1–10. doi:10.1186/1477-7517-10-2.
  • Broom, D. H. and R. Woodward. 1996. “Medicalisation Reconsidered: Toward a Collaborative Approach to Care.” Sociology of Health & Illness 18(3): 357–78. doi:10.1111/1467-9566.ep10934730.
  • Brown, Phil, Stephen Zavestoski, Sabrina McCormick, Brian Mayer, Rachel Morello-Frosch, and Rebecca Gasior Altman. 2004. “Embodied Health Movements: New Approaches to Social Movements in Health.” Sociology of Health & Illness 26(1): 50–80. doi:10.1111/j.1467-9566.2004.00378.x.
  • Campbell, Nancy D. 2012. “Medicalization and Biomedicalization: Does the Diseasing of Addicting Fit the Frame?” Advances in Medical Sociology 14: 3–25.
  • Castaneda, C. 1968. The Teachings of Don Juan: A Yaqui Way of Knowledge. Berkeley: University of California Press.
  • Centers for Disease Control and Prevention (CDC). 2018. “Well-Being Concepts.” Centers for Disease Control and Prevention. Accessed September 12, 2021. https://www.cdc.gov/hrqol/wellbeing.htm
  • Chapkis, Wendy. 2007. “Cannabis, Consciousness, and Healing.” Contemporary Justice Review 10(4): 443–60. doi:10.1080/10282580701677550.
  • Choo, Esther K., Sarah W. Feldstein, and Travis I. Lovejoy. 2016. “Opioids Out, Cannabis In: Negotiating the Unknowns in Patient Care for Chronic Pain.” Journal of the American Medical Association 316(17): 1763–64. doi:10.1001/jama.2016.13677.
  • Conrad, Peter. 1979. “Types of Medical Social Control.” Sociology of Health & Illness 1(1): 1–11. doi:10.1111/1467-9566.ep11006751.
  • Conrad, Peter. 1992. “Medicalization and Social Control.” Annual Review of Sociology 18(1): 209–32. doi:10.1146/annurev.so.18.080192.001233.
  • Conrad, Peter. 2005. “The Shifting Engines of Medicalization.” Journal of Health and Social Behavior 46(1): 3–14. doi:10.1177/002214650504600102.
  • Conrad, Peter. 2007. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore, MD: John Hopkins University Press.
  • Conrad, Peter and Valerie Leiter. 2004. “Medicalization, Markets and Consumers.” Journal of Health and Social Behavior 45: 158–76.
  • Conrad, Peter and Joseph W. Schneider. [1980] 1992. Deviance and Medicalization: From Badness to Sickness. Philadelphia, PA: Temple University Press.
  • Craig, Jones and Andrew D. Hathaway. 2008. “Marijuana Medicine and Canadian Physicians: Challenges to Meaningful Drug Policy Reform.” Contemporary Justice Review 11(2): 165–75. doi:10.1080/10282580802058429.
  • DeAngelo, Steve. 2015. The Cannabis Manifesto: A New Paradigm for Wellness. Berkeley, CA: North Atlantic Books.
  • Dioun, C. 2018. “Negotiating Moral Boundaries: Social Movements and the Strategic (Re)definition of the Medical in Cannabis Markets.” Research in the Sociology of Organisations 56: 53–82.
  • Dumit, Joseph. 2012. Drugs for Life: How Pharmaceutical Companies Define Our Health. Durham, NC: Duke University Press.
  • Fischer, Benedikt, Yoko Murphy, Paul Kurdyak, Elliot Goldner, and Jurgen Rehm. 2015. “Medical Marijuana Programs: Why Might They Matter for Public Health and Why Should We Better Understand Their Impacts?” Preventative Medicine Reports 2: 53–56. doi:10.1016/j.pmedr.2014.12.006.
  • Frye, Patricia C. 2018. The Medical Marijuana Guide: Cannabis and Your Health. Lanham, MD: Rowman & Littlefield.
  • Garner, Emily. 2016. “A Phenomenology of Marijuana Use among Graduate Students.” Indo-Pacific Journal of Phenomenology 16(sup1): 111–27. doi:10.1080/20797222.2016.1164997.
  • Grinspoon, Lester. 1999. “Medical Marihuana in a Time of Prohibition.” International Journal of Drug Policy 10(2): 145–56. doi:10.1016/S0955-3959(99)00009-2.
  • Haines, Rebecca J., Joy L. Johnson, Connie I. Carter, and Kamal Arora. 2009. “’I Couldn’t Say I’m Not a Girl’—Adolescents Talk about Gender and Marijuana Use.” Social Science & Medicine 68(11): 2029–36. doi:10.1016/j.socscimed.2009.03.003.
  • Hall, Wayne and Michael Lynskey. 2016. “Evaluating the Public Health Impacts of Legalising Recreational Cannabis Use in the United States.” Addiction 111(10): 1764–73. doi:10.1111/add.13428.
  • Haug, Nancy A., Dustin Kieschnick, James E. Sottile, Kimberly A. Babson, Ryan Vandrey, and Marcel O. Bonn-Miller. 2016. “Training and Practices of Cannabis Dispensary Staff.” Cannabis and Cannabinoid Research 1(1): 244–51. doi:10.1089/can.2016.0024.
  • Health Canada. 2019. “Data on Cannabis for Medical Purposes.” Accessed June 3, 2019. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/medical-purpose.html.
  • Hollander, Jocelyn A. 2004. “The Social Contexts of Focus Groups.” Journal of Contemporary Ethnography 33(5): 602–37. doi:10.1177/0891241604266988.
  • Jarvinen, Margaretha and Jakob Demant. 2011. “The Normalisation of Cannabis Use among Young People: Symbolic Boundary Work in Focus Groups.” Health, Risk & Society 13(2): 165–82. doi:10.1080/13698575.2011.556184.
  • Johnson, R. Burke. 2000. “Examining the Validity Structure of Qualitative Research.” Pp. 119–24. in Understanding Research Methods, 2nded., edited by M. L Patten. Los Angeles, CA: Pyrczak Publishing.
  • Kahan, Meldon and Anita Srivastava. 2007. “Is There a Role for Marijuana in Medicinal Practice? No.” Canadian Family Physician 53(1): 22–25.
  • Kleber, H. D. and R.L. DuPont. 2012. “Physicians and Medical Marijuana.” American Journal of Psychiatry 169(6): 564–68. doi:10.1176/appi.ajp.2012.12030373.
  • Kondrad, Elin and Alfred Reid. 2013. “Colorado Family Physicians‘ Attitudes Toward Medical Marijuana.” Journal of the American Board of Family Medicine 26(1): 52–60. doi:10.3122/jabfm.2013.01.120089.
  • Krieger, N. 1994. “Epidemiology and the Web of Causation: Has Anyone Seen the Spider?” Social Science & Medicine 39(7): 887–903. doi:10.1016/0277-9536(94)90202-X.
  • Krueger, Richard A. and Mary Anne Casey. 2009. Focus Groups: A Practical Guide for Applied Research. Thousand Oaks, CA: Sage.
  • Kruger, Daniel J. and Jessica S. Kruger. 2019. “Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine.” Journal of Psychoactive Drugs 51(1): 31–36. doi:10.1080/02791072.2018.1563314.
  • Lankenau, S. E., A. Kioumarsi, M. Reed, M. McNeeley, E. Iverson, and C. F. Wong. 2018. “Becoming a Medical Marijuana User.” International Journal of Drug Policy 52: 62–70. doi:10.1016/j.drugpo.2017.11.018.
  • Lee, Martin A. 2012. Smoke Signals: A Social History of Marijuana—Medical, Recreational, and Scientific. New York: Simon & Schuster.
  • McCarthy, K. T. 2004. “Conversations about Medical Marijuana between Physicians and Their Patients.” The Journal of Legal Medicine 25(3): 333–49. doi:10.1080/01947640490497015.
  • Michelle, Sexton, Carrie Cuttler, John S. Finnell, and Laurie K. Mischley. 2016. “A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy.” Cannabis and Cannabinoid Research 1(1): 131–38. doi:10.1089/can.2016.0007.
  • Morgan, David L. 1997. Focus Groups as Qualitative Research. Thousand Oaks, California: Sage.
  • National Conference of State Legislatures (NCSL). 2021 August 23. State Medical Marijuana Laws. National Conference of State Legislatures. https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
  • Newhart, Michelle and William Dolphin. 2019. The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience. New York: Routledge.
  • Nussbaum, Abraham M., Jonathan A. Boyer, and Elin C. Kondrad. 2011. “’But My Doctor Recommended Pot’: Medical Marijuana and the Patient-Physician Relationship.” Journal of General Internal Medicine 26(11): 1364–67. doi:10.1007/s11606-011-1840-4.
  • O’Brien, Patrick K. 2013. “Medical Marijuana and Social Control: Escaping Criminalisation and Embracing Medicalization.” Deviant Behavior 34(6): 423–43. doi:10.1080/01639625.2012.735608.
  • Page, Stacy A. and Marja J. Verhoef. 2006. “Medical Marijuana Users: Experiences of People with Multiple Sclerosis.” Canadian Family Physician 52: 65–77.
  • Pedersen, Willy. 2015. “From Badness to Illness: Medical Cannabis and Self-Diagnosed Attention Deficit Hyperactivity Disorder.” Addiction Research & Theory 23(3): 177–86. doi:10.3109/16066359.2014.954556.
  • Pedersen, Willy and Sveinung Sandberg. 2013. “The Medicalization of Revolt: A Sociological Analysis of Medical Cannabis Users.” Sociology of Health & Illness 35(1): 17–32. doi:10.1111/j.1467-9566.2012.01476.x.
  • Penn, Rebecca A. 2014. “Establishing Expertise: Canadian Community-Based Medical Cannabis Dispensaries as Embodied Health Movement Organisations.” International Journal of Drug Policy 25(3): 372–77. doi:10.1016/j.drugpo.2013.12.003.
  • Peter, Conrad and Kristin K. Barker. 2010. “The Social Construction of Illness: Key Insights and Policy Implications.” Journal of Health and Social Behavior 51(S): S67–S79. doi:10.1177/0022146510383495.
  • Reid, M. 2021. “Troubling Claims of Normalization: Continuing Stigmas within Michigan’s Medical Cannabis Community.” Deviant Behavior. 1–20. doi:10.1080/01639625.2021.1953947.
  • Rendon, Jim. 2012. Super Charged: How Outlaws, Hippies, and Scientists Reinvented Marijuana. Portland, OR: Timber Press.
  • Reveley, J. 2016. “Neoliberal Meditations: How Mindfulness Training Medicalizes Education and Responsibilizes Young People.” Policy Futures in Education 14(4): 497–511. doi:10.1177/1478210316637972.
  • Rosa, W. E., S. Hope, and M. Matzo. 2019. “Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care.” Journal of Holistic Nursing 37(1): 100–06. doi:10.1177/0898010118770302.
  • Roubein, Rachel 2019. “The Budtender Will See You Now.” Politico.com, December 7. https://www.politico.com/news/2019/12/07/the-budtender-will-see-you-now-077314.
  • Rubens, Muni. 2014. “Political and Medical Views on Medical Marijuana and Its Future.” Social Work in Public Health 29(2): 121–31. doi:10.1080/19371918.2013.821351.
  • Ryan, Jennie and Nancy Sharts-Hopko. 2017. “The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.” Journal of Neuroscience Nursing 49(3): 185–90. doi:10.1097/JNN.0000000000000283.
  • Sandelowski, M. 1995. “Sample Size in Qualitative Research.” Research in Nursing & Health 18(2): 179–83. doi:10.1002/nur.4770180211.
  • Satterlund, Travis D., Juliet P. Lee, and Roland S. Moore. 2015. “Stigma Among California’s Medical Marijuana Patients.” Journal of Psychoactive Drugs 47(1): 10–17. doi:10.1080/02791072.2014.991858.
  • Shim, Janet K. 2010. “Cultural Health Capital: A Theoretical Approach to Understanding Health Care Interactions and the Dynamics of Unequal Treatment.” Journal of Health and Social Behavior 51(1): 1–15. doi:10.1177/0022146509361185.
  • Sointu, Eeva. 2006. “The Search for Wellbeing in Alternative and Complementary Health Practices.” Sociology of Health & Illness 28(3): 330–49. doi:10.1111/j.1467-9566.2006.00495.x.
  • Stith, S. S. and J. M. Vigil. 2016. “Federal Barriers to Cannabis Research.” Science 352(6290): 1182. doi:10.1126/science.aaf7450.
  • U.S. Drug Enforcement Administration (DEA). 1988. Marijuana Rescheduling Petition, DEA Docket No. 86–22. United States Department of Justice, Drug Enforcement Administration.
  • Victorson, David, Megan McMahon, Bruriah Horowitz, Sydney Glickson, Brandy Parker, and Leslie Mendoza-Temple. 2019. “Exploring Cancer Survivors’ Attitudes, Perceptions, and Concerns about Using Medical Cannabis for Symptom and Side Effect Management: A Qualitative Focus Group Study.” Complementary Therapies in Medicine 47: 1–8. doi:10.1016/j.ctim.2019.102204.
  • Webb, C. W. and S. M. Webb. 2014. “Therapeutic Benefits of Cannabis: A Patient Survey.” Hawaii Journal of Medicine & Public Health 73(4): 109–11.
  • Weiss, G.L. and D.A. Copelton. 2021. The Sociology of Health, Healing, and Illness. 10th ed. New York: Routledge.
  • Wendy, Chapkis and Richard J. Webb. 2008. Dying to Get High: Marijuana as Medicine. New York: New York University Press.
  • Werner, C.A. 2001. “Medical Marijuana and the AIDS Crisis.” Journal of Cannabis Therapeutics 1(3/4): 17–33. doi:10.1300/J175v01n03_03.
  • Williams, S. J., P. Martin, and J. Gabe. 2011. “The Pharmaceuticalisation of Society? A Framework for Analysis.” Sociology of Health & Illness 33(5): 710–25. doi:10.1111/j.1467-9566.2011.01320.x.
  • Zaller, N., A. Topletz, S. Frater, G. Yates, and M. Lally. 2015. “Profiles of Medicinal Cannabis Patients Attending Compassion Centers in Rhode Island.” Journal of Psychoactive Drugs 47(1): 18–23. doi:10.1080/02791072.2014.999901.
  • Zolotov, Y., Y. Baruch, H. Reuveni, and R. Magnezi. 2016. “Adherence to Medical Cannabis among Licensed Patients in Israel.” Cannabis and Cannabinoid Research 1(1): 16–21. doi:10.1089/can.2015.0003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.